D

ATS 2022: Clinical Improvement in Pulmonary Arterial Hypertension (PAH) Patients Transitioning From Selexipag to Oral Treprostinil: Interim Results From the ADAPT Registry

By Daniel Lachant 2 Videos
178 views
May 26, 2022
0 Comments
Login to view comments. Click here to Login

Featured Video

04:42
Merck

Epidemiology and Serotypes Associated With Invasive Pneumococcal Dis…

Featured Video

05:09
Merck

Risk and Severity of Pneumococcal Disease in Adults

Related Content

AUTOPLAY
16:13
3rd Advanced Lung Disease: Novel Therapies and Controversies Conference

Post COVID-19 Lung Complications

Feat. M. Padilla
26:02
Mayo Clinic Pulmonary and Critical Care Educational Series

Right Heart Failure Secondary to Non-Group 1 PH

Feat. H. Cajigas
31:36
Keck School of Medicine of USC

Pulmonary Manifestations of SLE: An Update

Feat. F. Quismorio
08:01
PERT Consortium 2022

Update on HI-PEITHO - A Landmark Clinical Trial in PE

Feat. K. Rosenfield
12:18
PERT Consortium 2022

Catheter-Directed Thrombolysis Is the Preferred Approach for the Tre…

Feat. P. Monteleone
13:30
ACC 2023 Conference Coverage

ACC 2023: Clinical Manifestations of Right Ventricular Failure

Feat. J. Huston
33:44
Scripps Health

New Therapies for Pulmonary Venous Hypertension: Updates on the Trea…

Feat. R. C. Mohan
49:41
Sandeep Sahay

Pulmonary Arterial Hypertension: Update on Diagnosis and Management

22:00
CHEST 2023 Insights

CHEST 2023 Insights: Pulmonary Hypertension Treatment - How to Start…

Feat. J. Elwing
25:35
ATS 2023 Insights

ATS 2023 Insights: Pulmonary Vascular Disease - Clinical Year in Rev…

Feat. G. Heresi
11:01
Brandon Croft

The Social Determinants of Health in Methamphetamine Induced Pulmona…

30:19
UCLA Health

Link Between Parenchymal Lung Disease and PH

Feat. R. Saggar
49:54
Temple Lung Center

Pulmonary Arterial Hypertension and Risk Stratification

Feat. S. Sahay
36:33
Temple Lung Center

Sotatercept FDA Approval: A New Dawn in PAH Treatment

Feat. A. Raza
10:07
Inova Cherry Blossom Cardiovascular Symposium 2022

RV Failure and Pulmonary Hypertension

Feat. M. Psotka
14:06
3rd Advanced Lung Disease: Novel Therapies and Controversies Conference

Understanding Some of the Cellular Mechanisms of Familial PAH

Feat. L. Pandit
08:54
Zeenat Safdar

ATS 2022: Midodrine as a Novel Tool to Optimize Pulmonary Hypertensi…

46:27
Sentara's 10th Annual Pulmonary Hypertension Symposium

The Long and Winding Road: The Continuing Mission to Educate Our Reg…

Feat. M. Eggert
35:09
Sentara's 10th Annual Pulmonary Hypertension Symposium

ECHO Evaluation in Pulmonary Hypertension

Feat. E. Sawey
13:47
CHEST 2022 Coverage

Lessons From 2020: Representation of Minorities in Pulmonary Artery …

Feat. V. Balasubramanian